| __timestamp | Supernus Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 91733000 |
| Thursday, January 1, 2015 | 89204000 | 87644000 |
| Friday, January 1, 2016 | 106010000 | 92365000 |
| Sunday, January 1, 2017 | 137905000 | 85656000 |
| Monday, January 1, 2018 | 159888000 | 88196000 |
| Tuesday, January 1, 2019 | 158425000 | 89971000 |
| Wednesday, January 1, 2020 | 200677000 | 93413000 |
| Friday, January 1, 2021 | 304759000 | 91355000 |
| Saturday, January 1, 2022 | 377221000 | 113676000 |
| Sunday, January 1, 2023 | 336361000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Supernus Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have been navigating this financial landscape since 2014. Over the years, Supernus has seen a significant increase in SG&A expenses, peaking in 2022 with a 420% rise from 2014. In contrast, Taro's expenses have remained relatively stable, with a modest 139% increase over the same period. This suggests that Taro may have a more consistent approach to cost management. However, the data for 2024 is incomplete for Supernus, leaving room for speculation. As these companies continue to evolve, their strategies in optimizing SG&A costs will be pivotal in determining their financial health and competitive edge.
AbbVie Inc. or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? GSK plc or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Bio-Techne Corporation or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Catalent, Inc. vs Supernus Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Taro Pharmaceutical Industries Ltd.
Grifols, S.A. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Merus N.V. and Supernus Pharmaceuticals, Inc.
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Taro Pharmaceutical Industries Ltd.